Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
Elaine Liversidge0
Gary G. Liversidge0
Lawrence de Garavilla0
Date of Patent
October 26, 2010
Patent Application Number
12027100
Date Filed
February 6, 2008
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed are methods of intravenous administration of nanoparticulate drug formulations to a mammal to avoid adverse hemodynamic effects: by reducing the rate and concentration of the nanoparticles in the formulations; or by pre-treating the subject with histamine; or by pretreating the subject with a desensitizing amount of the nanoparticulate drug formulations.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
